e 4031 has been researched along with Astrocytoma, Grade IV in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glioblastoma is the most malignant primary brain tumor, with a median survival of less than 2 years." | 1.46 | Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients. ( Clark, PA; Eliceiri, KW; Kuo, JS; Pointer, KB; Robertson, GA; Salamat, MS, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pointer, KB | 1 |
| Clark, PA | 1 |
| Eliceiri, KW | 1 |
| Salamat, MS | 1 |
| Robertson, GA | 1 |
| Kuo, JS | 1 |
1 other study available for e 4031 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cel | 2017 |